Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer

Autor: Ekoue, DN, Ansong, E, Liu, L, Macias, Virgilia, Deaton, R, Lacher, C, Picklo, M, Nonn, Larisa, Gann, Peter, Kajdacsy-Balla, Andre, Prins, Gail, Freeman, Vincent L, Diamond, Alan

Background: Selenium status is inversely associated with the incidence of prostate cancer. However, supplementation trials have not indicated a benefit of selenium supplementation in reducing cancer risk. Polymorphisms in the gene encoding selenoprot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::57de8d46ebc9aff434fb18a81f0c03ef

A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells.

Autor: Roggero CM; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA., Jin L; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Cao S; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Sonavane R; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA., Kopplin NG; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA., Ta HQ; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA., Ekoue DN; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA., Witwer M; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA., Ma S; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA., Liu H; Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA., Ma T; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Gioeli D; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA., Raj GV; Department of Urology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA. ganesh.raj@utsouthwestern.edu.; Department of Pharmacology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA. ganesh.raj@utsouthwestern.edu., Dong Y; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA. ydong@tulane.edu.

Publikováno v: Oncogene [Oncogene] 2021 Feb; Vol. 40 (6), pp. 1106-1117. Date of Electronic Publication: 2020 Dec 15.

Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Autor: Wang S; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Shan.Wang@utsouthwestern.edu., Ekoue DN; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Raj GV; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA., Kittler R; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Ralf.Kittler@utsouthwestern.edu.

Publikováno v: Cancer letters [Cancer Lett] 2018 Dec 01; Vol. 438, pp. 86-96. Date of Electronic Publication: 2018 Sep 11.

A new class of agents for estrogen-receptor-positive breast cancer.

Autor: Ekoue DN; a Department of Urology , University of Texas Southwestern Medical Center , Dallas , TX , USA.; b Department of Pharmacology , University of Texas Southwestern Medical Center , Dallas , TX , USA., Unni N; c Department of Medical Oncology , University of Texas Southwestern Medical Center , Dallas , TX , USA., Raj GV; a Department of Urology , University of Texas Southwestern Medical Center , Dallas , TX , USA.; b Department of Pharmacology , University of Texas Southwestern Medical Center , Dallas , TX , USA.

Publikováno v: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2018 Apr; Vol. 11 (4), pp. 325-328.

Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis.

Autor: Ekoue DN; Department of Pathology and Medicine, University of Illinois at Chicago, Chicago, IL, United States., He C; Department of Pathology and Medicine, University of Illinois at Chicago, Chicago, IL, United States., Diamond AM; Department of Pathology and Medicine, University of Illinois at Chicago, Chicago, IL, United States., Bonini MG; Department of Pathology and Medicine, University of Illinois at Chicago, Chicago, IL, United States. Electronic address: mbonini@uic.edu.

Publikováno v: Biochimica et biophysica acta. Bioenergetics [Biochim Biophys Acta Bioenerg] 2017 Aug; Vol. 1858 (8), pp. 628-632. Date of Electronic Publication: 2017 Jan 11.